← Open Payments lookup

JEREMY DAVIS: Open Payments

NPI 1386997351 · SHREVEPORT, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$18,711 in 101 payments from 15 companies in 2025. Trend: 2023 $1,923 · 2024 $12,183 · 2025 $18,711

Speaker / faculty: $11,250Food & beverage: $5,220Travel & lodging: $1,392Consulting: $848
CompanyPaymentsAmount
Madrigal Pharmaceuticals30$12,122
Ipsen Biopharmaceuticals, Inc11$2,955
Mirum Pharmaceuticals, Inc.9$1,647
Gilead Sciences, Inc.13$924
ABBVIE INC.11$206
Takeda Pharmaceuticals U.S.A., Inc.10$151
Boston Scientific Corporation1$150
Phathom Pharmaceuticals, Inc.1$132
GENZYME CORPORATION6$131
Janssen Biotech, Inc.3$120

Products named: REZDIFFRA, IQIRVO, Livmarli, ENTYVIO, General - Hemostasis, VOQUEZNA, DUPIXENT, Livdelzi.

Industry payments across LA — which companies pay providers there.